Boulding Mark Elliott bought PTCT
May 8, 2026 · Form 4 insider transaction
Boulding Mark Elliott bought 2,740 shares of PTC Therapeutics, Inc. at $46.54 per share, a transaction worth $127.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,740
Price
$46.54
Total value
$127.5K
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 8, 2026
Filing dateMay 12, 2026
Shares owned after107,952
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025.